Bojko P - Search Results

1

Characterization of 35 new cases with four different MPLW515 mutations and essential thrombocytosis or primary myelofibrosis.

Schnittger S, Bacher U, Haferlach C, Beelen D, Bojko P, Bürkle D, Dengler R, Distelrath A, Eckart M, Eckert R, Fries S, Knoblich J, Köchling G, Laubenstein HP, Petrides P, Planker M, Pihusch R, Weide R, Kern W, Haferlach T. Schnittger S, et al. Among authors: bojko p. Haematologica. 2009 Jan;94(1):141-4. doi: 10.3324/haematol.13224. Epub 2008 Nov 23. Haematologica. 2009. PMID: 19029146 Free PMC article. No abstract available.

2

Mutations in the JAK2 and MPL genes and their correlation to clinical parameters in patients with chronic myeloproliferative disease.

Bojko P, Abenhardt W, Schnittger S, Haferlach T. Bojko P, et al. Onkologie. 2009 Apr;32(4):191-5. doi: 10.1159/000203332. Epub 2009 Mar 13. Onkologie. 2009. PMID: 19372714

3

Characteristics and outcomes of patients with cancer and COVID-19: results from a cohort study.

Höllein A, Bojko P, Schulz S, Neitz J, Stötzer O, Pihusch R, Abedinpour F, Schmidt B, Hentrich M. Höllein A, et al. Among authors: bojko p. Acta Oncol. 2021 Jan;60(1):24-27. doi: 10.1080/0284186X.2020.1863464. Epub 2021 Jan 5. Acta Oncol. 2021. PMID: 33397179 No abstract available.

4

Metronomic oral cyclophosphamide in patients with advanced solid tumors.

Bojko P, Schimmel G, Bosse D, Abenhardt W. Bojko P, et al. Onkologie. 2012;35(1-2):35-8. doi: 10.1159/000336144. Epub 2012 Jan 20. Onkologie. 2012. PMID: 22310343

5

[Treatment of chemotherapy-induced nausea and vomiting with 5-hydroxytryptamine type 3 receptor antagonists].

Abenhardt W, Bosse D, Böning L, Bojko P, Hitz H, Völkl S, Fromm M, Mittermüller J, Göldel N, Schick HD, Dietzfelbinger H, Hinke A. Abenhardt W, et al. Among authors: bojko p. Dtsch Med Wochenschr. 2006 Dec 1;131(48):2707-12. doi: 10.1055/s-2006-956293. Dtsch Med Wochenschr. 2006. PMID: 17123235 Clinical Trial. German.

6

Nivolumab in HIV-related non-small-cell lung cancer.

Hentrich M, Schipek-Voigt K, Jäger H, Schulz S, Schmid P, Stötzer O, Bojko P. Hentrich M, et al. Among authors: bojko p. Ann Oncol. 2017 Nov 1;28(11):2890. doi: 10.1093/annonc/mdx321. Ann Oncol. 2017. PMID: 29106466 Free article. No abstract available.

7

sCD25 as an independent adverse prognostic factor in adult patients with HLH: results of a multicenter retrospective study.

Wimmer T, Mattes R, Stemmler HJ, Hauck F, Schulze-Koops H, Stecher SS, Starck M, Wendtner CM, Bojko P, Hentrich M, Nickel KE, Götze KS, Bassermann F, von Bergwelt-Baildon M, Spiekermann K. Wimmer T, et al. Among authors: bojko p. Blood Adv. 2023 Mar 14;7(5):832-844. doi: 10.1182/bloodadvances.2022007953. Blood Adv. 2023. PMID: 35973195 Free PMC article.

8

High-dose chemotherapy with peripheral blood stem cell transplantation for patients with advanced ovarian cancer.

Bojko P, Scheulen ME, Hilger R, Oberhoff C, Schindler AE, Seeber S. Bojko P, et al. J Cancer Res Clin Oncol. 2001 Apr;127(4):243-50. doi: 10.1007/s004320000202. J Cancer Res Clin Oncol. 2001. PMID: 11315259

9

Outcome of 67 patients with solid tumors relapsed after high-dose chemotherapy and peripheral blood stem cell transplantation.

Bojko P, Akca A, Seeber S. Bojko P, et al. Bone Marrow Transplant. 2003 Jun;31(11):995-1000. doi: 10.1038/sj.bmt.1704047. Bone Marrow Transplant. 2003. PMID: 12774050

10

Femoral head necrosis in three patients with relapsed ovarian cancer receiving high-dose chemotherapy followed by autologous peripheral blood stem cell transplantation.

Bojko P, Hilger RA, Ruehm SG, Dirsch O, Seeber S, Scheulen ME. Bojko P, et al. Bone Marrow Transplant. 2003 Mar;31(6):487-91. doi: 10.1038/sj.bmt.1703886. Bone Marrow Transplant. 2003. PMID: 12665845

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

40 results

Search Page